Tolerance to NeuroEPO in Parkinson Disease

NCT04110678 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

26

Enrollment

OTHER

Sponsor class

Conditions

Parkinson Disease

Interventions

DRUG: NeuroEPO

Sponsor

International Center for Neurological Restoration, Cuba

Collaborators

[object Object]
[object Object]